Quoin Pharmaceuticals, Ltd. (ADR)
General ticker "QNRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.6M (TTM average)
Quoin Pharmaceuticals, Ltd. (ADR) follows the US Stock Market performance with the rate: 2.7%.
Estimated limits based on current volatility of 5.8%: low 17.58$, high 19.75$
Factors to consider:
- Total employees count: 5 (+25.0%) as of 2024
- Top business risk factors: Limited operating history, Regulatory and compliance, Third-party risks, Cybersecurity threats, Geopolitical risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.65$, 41.66$]
- 2025-12-31 to 2026-12-31 estimated range: [4.37$, 18.96$]
Financial Metrics affecting the QNRX estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -287.64 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: 41.86 < Shareholder equity ratio, % of 58.59 <= 63.39
- Negative: Investing cash flow per share per price, % of -69.13 <= -14.38
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term QNRX quotes
Long-term QNRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.26MM | $9.38MM | $9.53MM |
| Operating Income | $-9.26MM | $-9.38MM | $-9.53MM |
| Non-Operating Income | $-0.12MM | $0.69MM | $0.57MM |
| Interest Expense | $0.71MM | $0.00MM | $0.00MM |
| R&D Expense | $2.67MM | $3.31MM | $3.60MM |
| Income(Loss) | $-9.38MM | $-8.69MM | $-8.96MM |
| Profit(Loss)* | $-9.38MM | $-8.69MM | $-8.92MM |
| Stockholders Equity | $7.41MM | $5.66MM | $9.20MM |
| Assets | $14.46MM | $12.17MM | $15.71MM |
| Operating Cash Flow | $-8.48MM | $-7.86MM | $-7.86MM |
| Capital expenditure | $0.25MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-10.15MM | $2.19MM | $-1.89MM |
| Financing Cash Flow | $14.01MM | $5.22MM | $10.97MM |
| Earnings Per Share** | $-23.23 | $-337.46 | $-66.58 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.